Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Rashmi Chugh(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Catherine Van Poznak(University of Michigan), Anne F. Schott(University of Michigan), Lynda Hodges(University of Michigan), James M. Rae(University of Michigan), Pankaj Vats(University of Michigan), Jens Rueter(Jackson Laboratory), Fengyun Su(University of Michigan), Scott A. Tomlins(Stratasys (Israel)), Daniel F. Hayes(University of Michigan–Ann Arbor), Amy Gursky(University of Michigan), Kenneth J. Pienta(Johns Hopkins University), Sameek Roychowdhury(The Ohio State University Wexner Medical Center), Shanker Kalyana‐Sundaram(University of Michigan), Scott Y. H. Kim(National Institutes of Health Clinical Center), Rui Wang(University of Michigan), Ning Yu(University of Michigan), Yi-Mi Wu(University of Michigan), Lakshmi P. Kunju(University of Michigan), Robert J. Lonigro(University of Michigan), Javed Siddiqui(University of Michigan), Moshe Talpaz(University of Michigan)
Cited by 1,157
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009
|New England Journal of Medicine|2009|1.7k